Pasar al contenido principal

NANOSISTEMA POLIVALENTE CAPAZ DE APORTAR SOLUCIONES PARA HUESO INFECTADO, CON CANCER Y OSTEOPOROTICO.

MAT2015-64831-R

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos I+D+i Retos de Investigación
Año convocatoria 2015
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Unidad de gestión Dirección General de Investigación Científica y Técnica
Centro beneficiario UNIVERSIDAD COMPLUTENSE DE MADRID
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Mesoporous Bioactive Glasses Equipped with Stimuli-Responsive Molecular Gates for Controlled Delivery of Levofloxacin against Bacteria

  • Polo, Lorena
  • Gómez-Cerezo, N.
  • Arcos, Daniel
  • Vallet, María
  • García-Fernández, Alba|||0000-0002-8416-1674
  • Aznar, Elena|||0000-0003-0361-3876
  • Vivancos, José-Luis|||0000-0002-8524-5466
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] An increase of bone diseases incidence has boosted the study of ceramic biomaterials as potential osteo-inductive scaffolds. In particular, mesoporous bioactive glasses have demonstrated to possess a broad application in the bone regeneration field, due their osteo-regenerative capability and their ability to release drugs from the mesoporous structure. These special features have been studied as an option to fight against bone infection, which is one of the most common problems regarding bone regeneration therapies. In this work, a mesoporous bioglass functionalized with polyamines and capped with adenosine triphosphate (ATP) as the molecular gate was developed for the controlled release of the antibiotic levofloxacin. Phosphate bonds of ATP were hydrolyzed in the presence of acid phosphatase (APase), the concentration of which is significantly increased in bone infection due to the activation of bone resorption processes. The solid was characterized and tested successfully against bacteria. The final gated solid induced bacterial death only in the presence of acid phosphatase. Additionally, it was demonstrated that the solid is not toxic against human cells. The double function of the prepared material as a drug delivery system and bone regeneration enhancer confirms the possible development of a new approach in the tissue engineering field, in which controlled release of therapeutic agents can be finely tuned and, at the same time, osteoinduction is favored., The authors thank the Spanish Government for projects MAT2015-64139-C04-01-R, MAT2015-64831-R and MAT2016-75611-R (AEI/FEDER, UE). Generalitat Valenciana (project PROMETEOII/2014/047) and CIBER-BBN (project SPRING) are also acknowledged for their support. M.V.R. acknowledges funding from the European Research Council (Advanced Grant VERDI; ERC-2015-AdG Proposal 694160). L.P. thanks Universitat Politecnica de Valencia for her FPI grant. N.G.C. and A.G. thank to Ministerio de Ciencia e Innovacion and Ministerio de Educacion, Cultura y Deporte for their predoctoral fellowships. The authors also thank the Electron Microscopy Service at the UPV for their support.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Molecular gates in mesoporous bioactive glasses for the treatment of bone tumors and infection

  • Polo, Lorena
  • Gómez-Cerezo, Natividad
  • Arcos, Daniel
  • Vallet, María
  • Aznar, Elena|||0000-0003-0361-3876
  • Vivancos, José-Luis|||0000-0002-8524-5466
  • Sancenón Galarza, Félix|||0000-0002-5205-7135
  • Martínez-Máñez, Ramón|||0000-0001-5873-9674
[EN] Silica mesoporous nanomaterials have been proved to have meaningful application in biotechnology and biomedicine. Particularly, mesoporous bioactive glasses are recently gaining importance thanks to their bone regenerative properties. Moreover, the mesoporous nature of these materials makes them suitable for drug delivery applications, opening new lines in the field of bone therapies. In this work, we have developed innovative nanodevices based on the implementation of adenosine triphosphate (ATP) and e-poly-l-lysine molecular gates using a mesoporous bioglass as an inorganic support. The systems have been previously proved to work properly with a fluorescence probe and subsequently with an antibiotic(levofloxacin) and an antitumoral drug(doxorubicin). The bioactivity of the prepared materials has also been tested, giving promising results. Finally, in vitro cell culture studies have been carried out; demonstrating that this gated devices can provide useful approaches for bone cancer and bone infection treatments., Spanish Government for projects MAT2015-64139-C04-01-R, MAT-2013-43299-R, MAT2015-64831-R (MINECO/FEDER) and for project CS02010-11384-E (Agening-MICINN). Also, Generalitat Valenciana (project PROMETEOII/2014/047) and CIBER-BBN (project SPRING) are acknowledged for their support. MVR acknowledges funding from the European Research Council (Advanced Grant VERDI; ERC-2015-AdG Proposal No. 694160). LP thanks Universitat Politecnica de Valencia for her FPI grant. NGC is greatly indebted to Ministerio de Ciencia e Innovation for her predoctoral fellowship. The authors also wish to thank the staff of the ICTS Centro Nacional de Microscopia Electronica of the Universidad Complutense de Madrid (Spain) for the assistance in the scanning electron microscopy.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Beyond traditional hyperthermia: In vivo cancer treatment with magnetic-responsive mesoporous silica nanocarriers

  • Guisasola, Eduardo
  • Asín, Laura
  • Beola, Lilianne
  • Fuente, Jesús M. de la
  • Baeza, Alejandro
  • Vallet-Regí, María
In this study, we present an innovation in the tumor treatment in vivo mediated by magnetic mesoporous silica nanoparticles. This device was built with iron oxide magnetic nanoparticles embedded in a mesoporous silica matrix and coated with an engineered thermoresponsive polymer. The magnetic nanoparticles act as internal heating sources under an alternating magnetic field (AMF) that increase the temperature of the surroundings, provoking the polymer transition and consequently the release of a drug trapped inside the silica pores. By a synergic effect between the intracellular hyperthermia and chemotherapy triggered by AMF application, significant tumor growth inhibition was achieved in 48 h after treatment. Furthermore, the small magnetic loading used in the experiments indicates that the treatment is carried out without a global temperature rise of the tissue, which avoids the problem of the necessity to employ large amounts of magnetic cores, as is common in current magnetic hyperthermia., This work was supported by the European Research Council (Advanced Grant VERDI; ERC-2015-AdG Proposal No. 694160) and the project MAT2015-64831-R. L.B. thanks Santander-Universidad Zaragoza Fellowship program for her PhD position. L.A. thanks Juan de la Cierva Program for her postdoctoral possition., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Heating at the nanoscale through drug‐delivery devices: Fabrication and synergic effects in cancer treatment with nanoparticles

  • Guisasola, Eduardo
  • Baeza, Alejandro
  • Asín, Laura
  • Fuente, Jesús M. de la
  • Vallet-Regí, María
Nanocarriers for cancer therapy have been extensively studied, but there is still some research that must be addressed in order to achieve their safe application. In this field, hyperthermia thermal treatments mediated by the use of responsive nanomaterials are not different, and researchers have carried out many attempts to overcome their drawbacks due to the valuable potential of these techniques. Here, an overview is presented of nanodevices based on magnetic‐ and photoresponsive nanocrystals that respond to magnetic fields and/or near‐infrared stimuli for cancer therapies. Special attention is given to the synergic effect that can be achieved with nanoscale heating in combination with chemotherapy through drug‐delivery devices to effectively kill cancer cells. In this way, the nanoparticles act as heating sources or “hot spots,” which can trigger cellular responses in the absence of a global temperature rise, making the tumor cells more sensitive to chemotherapeutics. The fabrication of optical and magnetic drug‐delivery devices, the heating mechanisms, and their applications in tumor treatment are also summarized., This work was supported by the European Research Council (Advanced Grant VERDI; ERC-2015-AdG Proposal No. 694160, and Proof of Concept HOTFLOW; ERC-2016-POC Proposal No. 754609), the project MAT2015-64831-R, the project SAF2014-54763-C2-2-R, Fondo Social de la DGA (grupos DGA). L.A. acknowledges the Juan de la Cierva Program for her postdoctoral position., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Polydopamine-like coatings as payload gatekeepers for mesoporous silica nanoparticles

  • Moreno-Villaécija, Miguel Ángel
  • Sedó, Josep
  • Guisasola, Eduardo
  • Baeza, Alejandro
  • Vallet-Regí, María
  • Nador, Fabiana
  • Ruiz Molina, Daniel
We report the use of bis-catecholic polymers as candidates for obtaining effective, tunable gatekeeping coatings for mesoporous silica nanoparticles (MSNs) intended for drug release applications. In monomers, catechol rings act as adhesive moieties and reactive sites for polymerization, together with middle linkers which may be chosen to tune the physicochemical properties of the resulting coating. Stable and low-toxicity coatings (pNDGA and pBHZ) were prepared from two bis-catechols of different polarity (NDGA and BHZ) on MSN carriers previously loaded with rhodamine B (RhB) as a model payload, by means of a previously reported synthetic methodology and without any previous surface modification. Coating robustness and payload content were shown to depend significantly on the workup protocol. The release profiles in a model physiological PBS buffer of coated systems (RhB@MSN@pNDGA and RhB@MSN@pBHZ) showed marked differences in the “gatekeeping” behavior of each coating, which correlated qualitatively with the chemical nature of their respective linker moieties. While the uncoated system (RhB@MSN) lost its payload almost completely after 2 days, release from RhB@MSN@pNDGA was virtually negligible, likely due to the low polarity of the parent bis-catechol (NDGA). As opposed to these extremes, RhB@MSN@pBHZ presented the most promising behavior, showing an intermediate release of 50% of the payload in the same period of time., This work was supported by Projects MAT2015-70615-R from the Spanish Government and by FEDER funds. ICN2 acknowledges support from the Severo Ochoa Program (MINECO, Grant SEV-2013-0295) and the CERCA Programme/Generalitat de Catalunya. UCM acknowledges support by the European Research Council (Advanced Grant VERDI; ERC-2015-AdG Proposal No. 694160) and Project MAT2015-64831-R., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Superparamagnetic Iron Oxide Nanoparticles Decorated Mesoporous Silica Nanosystem for Combined Antibiofilm Therapy

  • Álvarez, Elena
  • Estévez, Manuel
  • Gallo-Cordova, Álvaro
  • González, Blanca
  • Castillo, Rafael R.
  • Morales, María Del Puerto
  • Colilla, Montserrat
  • Izquierdo-Barba, Isabel
  • Vallet-Regí, María
A crucial challenge to face in the treatment of biofilm-associated infection is the ability of bacteria to develop resistance to traditional antimicrobial therapies based on the administration of antibiotics alone. This study aims to apply magnetic hyperthermia together with controlled antibiotic delivery from a unique magnetic-responsive nanocarrier for a combination therapy against biofilm. The design of the nanosystem is based on antibiotic-loaded mesoporous silica nanoparticles (MSNs) externally functionalized with a thermo-responsive polymer capping layer, and decorated in the outermost surface with superparamagnetic iron oxide nanoparticles (SPIONs). The SPIONs are able to generate heat upon application of an alternating magnetic field (AMF), reaching the temperature needed to induce a change in the polymer conformation from linear to globular, therefore triggering pore uncapping and the antibiotic cargo release. The microbiological assays indicated that exposure of <i>E. coli</i> biofilms to 200 µg/mL of the nanosystem and the application of an AMF (202 kHz, 30 mT) decreased the number of viable bacteria by 4 log<sub>10</sub> units compared with the control. The results of the present study show that combined hyperthermia and antibiotic treatment is a promising approach for the effective management of biofilm-associated infections., This research was funded by the European Union’s Horizon 2020 research and innovation program under grant agreement No. 814410 (GIOTTO), the European Research Council under ERC-2015-AdG Proposal No. 694160 (VERDI) and the Ministerio de Ciencia e Innovación grant number PID2020-117091RB-I00. E.Á. thanks the financial support by FPI fellowship No. BES-2016-078767 from the Ministerio de Ciencia e Innovación., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Beyond Traditional Hyperthermia: In Vivo Cancer Treatment with Magnetic-Responsive Mesoporous Silica Nanocarriers

  • Guisasola, E.
  • Asín, L.
  • Beola, L.
  • Martinez De La Fuente, J.
  • Baeza, A.
  • Vallet-Regí, M.
In this study, we present an innovation in the tumor treatment in vivo mediated by magnetic mesoporous silica nanoparticles. This device was built with iron oxide magnetic nanoparticles embedded in a mesoporous silica matrix and coated with an engineered thermoresponsive polymer. The magnetic nanoparticles act as internal heating sources under an alternating magnetic field (AMF) that increase the temperature of the surroundings, provoking the polymer transition and consequently the release of a drug trapped inside the silica pores. By a synergic effect between the intracellular hyperthermia and chemotherapy triggered by AMF application, significant tumor growth inhibition was achieved in 48 h after treatment. Furthermore, the small magnetic loading used in the experiments indicates that the treatment is carried out without a global temperature rise of the tissue, which avoids the problem of the necessity to employ large amounts of magnetic cores, as is common in current magnetic hyperthermia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Polydopamine-like Coatings as Payload Gatekeepers for Mesoporous Silica Nanoparticles

  • Moreno Villaécija, Miguel Ángel|||0000-0003-2410-0682
  • Sedó Vegara, Josep|||0000-0002-4195-7541
  • Guisasola, Eduardo|||0000-0002-2549-1745
  • Baeza, Alejandro|||0000-0002-9042-8865
  • Vallet Regí, María|||0000-0002-6104-4889
  • Nador, Fabiana|||0000-0003-2502-0430
  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
We report the use of bis-catecholic polymers as candidates for obtaining effective, tunable gatekeeping coatings for mesoporous silica nanoparticles (MSNs) intended for drug release applications. In monomers, catechol rings act as adhesive moieties and reactive sites for polymerization, together with middle linkers which may be chosen to tune the physicochemical properties of the resulting coating. Stable and low-toxicity coatings (pNDGA and pBHZ) were prepared from two bis-catechols of different polarity (NDGA and BHZ) on MSN carriers previously loaded with rhodamine B (RhB) as a model payload, by means of a previously reported synthetic methodology and without any previous surface modification. Coating robustness and payload content were shown to depend significantly on the workup protocol. The release profiles in a model physiological PBS buffer of coated systems (RhB@MSN@pNDGA and RhB@MSN@pBHZ) showed marked differences in the "gatekeeping" behavior of each coating, which correlated qualitatively with the chemical nature of their respective linker moieties. While the uncoated system (RhB@MSN) lost its payload almost completely after 2 days, release from RhB@MSN@pNDGA was virtually negligible, likely due to the low polarity of the parent bis-catechol (NDGA). As opposed to these extremes, RhB@MSN@pBHZ presented the most promising behavior, showing an intermediate release of 50% of the payload in the same period of time.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Recent advances in porous nanoparticles for drug delivery in antitumoral applications, inorganic nanoparticles and nanoscale metal-organic frameworks

  • Baeza, Alejandro|||0000-0002-9042-8865
  • Ruiz-Molina, Daniel|||0000-0002-6844-8421
  • Vallet Regí, María|||0000-0002-6104-4889
Introduction: Nanotechnology has provided new tools for addressing unmet clinical situations, especially in the oncology field. The development of smart nanocarriers able to deliver chemotherapeutic agents specifically to the diseased cells and to release them in a controlled way has offered a paramount advantage over conventional therapy. Areas covered: Among the different types of nanoparticle that can be employed for this purpose, inorganic porous materials have received significant attention in the last decade due to their unique properties such as high loading capacity, chemical and physical robustness, low toxicity and easy and cheap production in the laboratory. This review discuss the recent advances performed in the application of porous inorganic and metal-organic materials for antitumoral therapy, paying special attention to the application of mesoporous silica, porous silicon and metal-organic nanoparticles. Expert opinion: The use of porous inorganic nanoparticles as drug carriers for cancer therapy has the potential to improve the life expectancy of the patients affected by this disease. However, much work is needed to overcome their drawbacks, which are aggravated by their hard nature, exploiting the advantages offered by highly the ordered pore network of these materials.